Literature DB >> 27432925

Prostate-Specific Antigen Screening: Time to Change the Dominant Forces on the Pendulum.

Jonathan E Shoag1, Peter N Schlegel1, Jim C Hu1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27432925      PMCID: PMC5074350          DOI: 10.1200/JCO.2016.67.8938

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  28 in total

1.  The Pendulum of Prostate Cancer Screening.

Authors:  David F Penson
Journal:  JAMA       Date:  2015-11-17       Impact factor: 56.272

2.  Early detection of prostate cancer: AUA Guideline.

Authors:  H Ballentine Carter; Peter C Albertsen; Michael J Barry; Ruth Etzioni; Stephen J Freedland; Kirsten Lynn Greene; Lars Holmberg; Philip Kantoff; Badrinath R Konety; Mohammad Hassan Murad; David F Penson; Anthony L Zietman
Journal:  J Urol       Date:  2013-05-06       Impact factor: 7.450

3.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-07-17       Impact factor: 25.391

4.  Reevaluating PSA Testing Rates in the PLCO Trial.

Authors:  Jonathan E Shoag; Sameer Mittal; Jim C Hu
Journal:  N Engl J Med       Date:  2016-05-05       Impact factor: 91.245

5.  Effective PSA contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.

Authors:  Suzie J Otto; Ingrid W van der Cruijsen; Michael K Liem; Ida J Korfage; Jan J Lous; Fritz H Schröder; Harry J de Koning
Journal:  Int J Cancer       Date:  2003-06-20       Impact factor: 7.396

6.  Extent of prostate-specific antigen contamination in the Spanish section of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Authors:  Marcos Luján; Alvaro Páez; Carlos Pascual; Javier Angulo; Elena Miravalles; Antonio Berenguer
Journal:  Eur Urol       Date:  2006-05-03       Impact factor: 20.096

7.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

8.  NCCN Clinical Practice Guidelines Prostate Cancer Early Detection, Version 2.2015.

Authors:  Peter R Carroll; J Kellogg Parsons; Gerald Andriole; Robert R Bahnson; Daniel A Barocas; Erik P Castle; William J Catalona; Douglas M Dahl; John W Davis; Jonathan I Epstein; Ruth B Etzioni; Thomas Farrington; George P Hemstreet; Mark H Kawachi; Paul H Lange; Kevin R Loughlin; William Lowrance; Paul Maroni; James Mohler; Todd M Morgan; Robert B Nadler; Michael Poch; Chuck Scales; Terrence M Shaneyfelt; Marc C Smaldone; Geoffrey Sonn; Preston Sprenke; Andrew J Vickers; Robert Wake; Dorothy A Shead; Deborah Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2015-12       Impact factor: 11.908

9.  Quantifying the role of PSA screening in the US prostate cancer mortality decline.

Authors:  Ruth Etzioni; Alex Tsodikov; Angela Mariotto; Aniko Szabo; Seth Falcon; Jake Wegelin; Dante DiTommaso; Kent Karnofski; Roman Gulati; David F Penson; Eric Feuer
Journal:  Cancer Causes Control       Date:  2007-11-20       Impact factor: 2.506

10.  Correlates of prostate-specific antigen testing in a large multiethnic cohort.

Authors:  Reina Haque; Stephen K Van Den Eeden; Steven J Jacobsen; Bette Caan; Chantal C Avila; Jeff Slezak; Barbara Sternfeld; Ronald K Loo; Virginia P Quinn
Journal:  Am J Manag Care       Date:  2009-11       Impact factor: 2.229

View more
  1 in total

1.  Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection.

Authors:  Montserrat Ferrer-Batallé; Esther Llop; Manel Ramírez; Rosa Núria Aleixandre; Marc Saez; Josep Comet; Rafael de Llorens; Rosa Peracaula
Journal:  Int J Mol Sci       Date:  2017-04-17       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.